Informations techniques
Exploitant
Laboratoires PROSTRAKAN PHARMA
Présentation
DROLEPTAN 2,5 mg/ 1ml, solution injectable (IV) B/10 - CIP 561 122-8
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
xFPQHXP9C4QJq7kY